4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-016092
Chief Financial Officer gave up 7,162 shares (to pay taxes)
- Chief Financial Officer acquired 25,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2020-03-02 | Option exercise | +25,750 | 195,117 | D | ||
| Ruffo Frank Chief Financial Officer | 2020-03-02 | Shares withheld for taxes | −7,162 | $1.26 | $9,024 | 187,955 | D |
| Derivatives | |||||||
| Ruffo Frank Chief Financial Officer | 2020-03-02 | Option exercise · Restricted stock units | −25,750 | 77,250 | D | ||
| Ruffo Frank Chief Financial Officer | 2020-03-02 | Grant or award · Employee Stock Option (Right to Buy) | +116,160 | 116,160 | D | ||
| Ruffo Frank Chief Financial Officer | 2020-03-02 | Grant or award · Restricted stock units | +66,377 | 66,377 | D | ||
| Ruffo Frank Chief Financial Officer | 2020-03-02 | Grant or award · Restricted stock units | +33,189 | 33,189 | D | ||
Loading xslF345X03/doc4.xml…